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Abstract
Background: The Paris Declaration on Aid Effectiveness, which provides an international agreement on how to
deliver aid, has recently been reviewed by the Organization for Economic Co-operation and Development (OECD).
Health sector aid effectiveness is important, given the volume of financial aid and the number of mechanisms
through which health assistance is provided. Recognizing this, the international community created the
International Health Partnership (IHP+), to apply the Paris Declaration to the health sector. This paper, which
presents findings from an independent monitoring process (IHP+Results), makes a valuable contribution to the
literature in the context of the recent 4th High Level Forum on Aid Effectiveness in Busan, Korea.
Methods: IHP+Results monitored commitments made under the IHP + using an agreed framework with twelve
measures for IHP +Development Partners and ten for IHP + recipient country governments. Data were collected
through self-administered survey tools. IHP+Results analyzed these data, using transparent criteria, to produce
Scorecards as a means to highlight progress against commitments and thereby strengthen mutual accountability
amongst IHP + signatories.
Results: There have been incremental improvements in the strengthening of national planning processes and
principles around mutual accountability. There has also been progress in Development Partners aligning their support
with national budgets. But there is a lack of progress in the use of countries’ financial management and procurement
systems, and in the integration of duplicative performance reporting frameworks and information systems.
Discussion and Conclusions: External, independent monitoring is potentially useful for strengthening accountability in
health sector aid. While progress in strengthening country ownership, harmonisation and alignment seems evident,
there are ongoing challenges. In spite of some useful findings, there are limitations with IHP+monitoring that need to
be addressed. This is not surprising given the challenge of rigorously monitoring Development Partners across multiple
recipient countries within complex global systems. The findings presented here suggest that the health sector is ahead
of the game – in terms of having an established mechanism to promote alignment and harmonisation, and a relatively
advanced monitoring framework and methods. But to capitalise on this, IHP+ signatories should: a) reaffirm their
commitments to the IHP+; b) actively embrace and participate in monitoring and evaluation processes; and c)
strengthen in-country capacity notably amongst civil society organizations.
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Background
On the 5th of September 2011, the International Health
Partnership and related initiatives (IHP+) celebrated its
fourth anniversary. In 2007 26 signatories signed the
IHP+Global Compact with a commitment to ‘work ef-
fectively together with renewed urgency to build sustain-
able health systems and improved health outcomes’. The
Compact committed signatories to making concrete the
2005 Paris Declaration of Aid Effectiveness in the field
of health: to improve aid coordination; increase the pre-
dictability of donor aid flows; work towards strengthened
country health systems; and renew commitment to mu-
tual accountability and transparency. Importantly, it also
committed to independent monitoring of IHP + signator-
ies’ efforts to improve aid effectiveness (see below for
more details). Today the IHP+ enjoys an expanded con-
stituency (Table 1), and has demonstrated its commitment
to independent assessment and accountability by commis-
sioning in 2009 a partnership known as IHP+Results to in-
dependently monitor progress against agreed indicators.
On the 29th November 2011 senior representatives of
the global aid industry met at the Fourth High Level
Forum in Busan, South Korea, to review their collective
efforts in improving the effectiveness of aid.a This paper,
which presents findings from IHP+Results monitoring in
2010, makes a timely and valuable contribution to the
literature in the context of Busan.
Key features of the International Health Partnership (IHP+)
IHP+Global Compact defines commitments following
the Paris principles of:
 National ownership
 Alignment with national systems
 Harmonization between agencies
 Managing for results
 Mutual accountability
The intended benefits for developing countries are [1]:
 Improved results through better use of existing
funds
 Improved harmonization and alignment of aid to
reduce fragmentation and transaction costs
 Improved coordination between country
governments and Development Partners
 Strengthened mutual accountability and
transparency, progressively involving all stakeholders
in existing national planning and monitoring
processes
 Long-term predictable financing for strengthening
health systems
 Stronger government leadership in sector
coordination
How does IHP+work?
IHP + encourages increased support for one national
health plan through
 Support to national sector planning processes
 Creating greater confidence in national plans by
encouraging joint assessment of their strengths and
weaknesses
 More unified modalities for partner support to the
plan, with the development or strengthening of
country compacts [2]
 One results monitoring framework to track plan
implementation
 Greater mutual accountability by monitoring
progress against compact commitments [3]
The day-to-day work of the Partnership is facilitated
through a Core Team jointly hosted by the World Health
Organization (WHO) and the World Bank [4], reporting
to the IHP+Executive Team and the IHP+ Scaling Up
Reference Group (SuRG).
The multiple problems of aid – generally and for health
specifically - are long recognised and have been widely
reported. Although the last two decades have seen a
substantial increase in development assistance for health
from $5B in 1990 to $21.8B in 2007 [5], all too commonly
aid for health programs is not used effectively, and in
some cases has negative consequences for recipient
countries [6-19]. Lack of predictability is an important
problem, both in terms of timely disbursement of aid, and
Table 1 IHP+ Signatories
Original signatories New signatories
Bilateral
agencies
Canada; France;
Germany; Italy;
Netherlands; Norway;
Portugal;UK.
Australia, Belgium; Spain;
Finland; Sweden
Multilateral
agencies
African Development
Bank (AfDB); European
Commission (EC);
UNAIDS; UNDP;
UNFPA; UNICEF; WHO;
World Bank.
OECD-DAC; ILO
GHPs GAVI Alliance (GAVI);
Global Fund to Fight
AIDS, TB and Malaria
(Global Fund)
Private
Foundations
The Bill & Melinda
Gates Foundation
Country
governments
Burundi; Cambodia;
Ethiopia; Kenya;
Mozambique;
Nepal; Zambia
Burkina Faso; Ghana;
Mali; Madagascar; Niger;
Nigeria;Cameroon; Chad;
Democratic Republic of
Congo (DRC); Djibouti;
El Salvador; Mauritania;
Pakistan; Rwanda; Senegal;
Sierra Leone; Sudan;
Togo; Uganda; Vietnam
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the tendency for donors to make short-term financial
commitments. It is damaging not only because it reduces
the value of aid by 15-20% [6], but it can also increase
fiscal and monetary instability in recipient countries,
which can heighten inflation [7]. Increases in health aid
occurred in parallel with a proliferation of global health
actors, which has heightened concerns about poor
harmonization, as well as limited alignment between
donor programs and country priorities. Dodd et al. [8]
state: ‘. . . there are now well over a 100 major inter-
national organizations involved in health, far more than
in any other sector, and literally hundreds of channels for
delivering health aid’. Most donors have their own
approaches and procedures that place substantial demands
on fragile recipient country health systems [9-12]. Lack of
accountability and transparency are also critical shortcom-
ings: many development agencies reveal little about how
and why decisions are made, and are more accountable to
donors and tax payers in high income countries than to
recipients or beneficiaries in low income countries [13].
Many commentators further suggest that donor govern-
ment national security, economic and foreign policy inter-
ests drive and explain donor behaviour rather than the
health needs of people in low-income countries [14,15]. It
is therefore not surprising to see a lack of ownership of
health programs from recipient country governments,
which undermines government accountability to their own
populations.
A multitude of national and international declarations
and initiatives have been launched with the objective of
improving the effectiveness of development assistance for
health programs [15,16] (see Table 2). The principles
articulated in the Paris Declaration on Aid Effectiveness,
which was endorsed by over 100 signatories, have galva-
nized commitments from both Development Partners and
recipient governments to work towards improving aid ef-
fectiveness. The Paris agenda was enthusiastically adopted
by the health sector with the launch of the IHPIHP+.
From the start, there have been concerns expressed that
the IHP+will turn out to be more rhetoric than real: the
latest in a long line of failed declarations and initiatives to
reduce some of the damaging effects of uncoordinated
and misdirected aid. This paper sheds light on this ques-
tion by critically assessing the progress made by the IHP+.
It draws on the monitoring conducted by IHP+Results in
2010 [17] (the methods are described below), and dis-
cusses it in relation to broader aid effectiveness monitor-
ing. Below we examine the extent to which Development
Partners and recipient governments’ IHP+ commitments
are being demonstrated through changes in the ways they
work; we reflect on a methodology used to monitor the
implementation of IHP+ commitments, and raise ques-
tions and recommendations that remain relevant both in
the aftermath of the 4th High Level Forum on Aid Effect-
iveness and to the future of the IHP+.
Methods
IHP+Results is an independent north–south consortium
of research and advocacy organisations, mandated by
IHP+ signatories to provide an annual assessment of the
implementation of the commitments set out in the
IHP+Global Compact [18]. The reporting framework
used by IHP+Results was agreed by all IHP+ signatories.
A set of ten measures for IHP + country governments
and twelve for Development Partners were agreed, based
closely on the Paris Declaration indicators and selected
to track progress against the results expected. Targets
for each indicator were agreed, drawing on Paris Declar-
ation targets where applicable; and finalised by IHP+Results
in conjunction with the IHP+Working Group on Mutual
Accountability (consisting of a time-limited group of IHP+
signatories mandated to agree to a monitoring framework
for use by IHP+Results). A timeframe for data collection
and analysis, including presentation of results through
‘Scorecards’ (described below), was also agreed by IHP+
signatories. Participation in the monitoring process - con-
sisting of agreement to provide data against the agreed
framework, and for a Scorecard to be produced - was on a
voluntary basis. Twenty-five IHP + signatories opted
to participate in 2010 (see below).
Table 2 Major aid effectiveness declarations, initiatives
and processes
1980s National AIDS Commissions (NACs) or equivalent
1997 Sector Wide Approaches (SWAPs)
Poverty Reduction Strategies
2001 Global Fund Country Coordination Mechanisms
2002 Monterrey Consensus on Financing for Development
2003 Rome Declaration of Harmonisation
2004 The ‘Three Ones’ Principles
2004 Joint Marrakech Memorandum on Managing for Results
2005 Paris Declaration on Aid Effectiveness
2005 Global Task Team on Improving AIDS Coordination among
Multilateral Institutions and International Donors
2006 UN’s ‘Delivering as One’
2007 Health 8 Agencies (H8)
2007 Global Implementation Support Team
2007 Global Campaign for the Health MDGs
2007 International Health Partnership (IHP+) Global Compact
2008/9 International Health Partnership (IHP+) Country Compacts
2008 Health Systems Funding Platform
2008 Accra Third High Level Forum on Aid Effectiveness
2011 Global Fund National Strategy Applications (NSAs)
2011 Busan Fourth High Level Forum on Aid Effectiveness
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Participants in IHP+Results 2010 monitoring
10 IHP± country governments: Burkina Faso, Burundi,
Djibouti, DRC, Ethiopia, Mali, Mozambique, Nepal, Niger
and Nigeria
15 Development Partners: AusAID, Belgium, EC, GAVI,
Global Fund, Netherlands, Norway, Spain, Sweden, UK,
UNAIDS, UNFPA, UNICEF, WHO and World Bank
To collect data, IHP+Results used a self-administered
survey that would be completed by both Development
Partners and recipient governments. The survey drew
far as possible on the OECD/DAC guidance for the 2011
Survey on Monitoring the Paris Declaration. Survey
tools and guidance documentation were made available
in English and French.
Participants had six weeks to complete the survey and.
Development Partners reported data for those countries
in which they considered themselves to be active, from
amongst the ten countries participating in the survey.
The IHP+Results team provided support to survey
participants throughout the data collection process.
IHP+Results reviewed the completed survey tools and
cleaned the data to maintain consistent application of
guidance on key terms and definitions. Data reported by
Development Partners for each recipient country were
aggregated using a weighted method (see below) for the
purposes of providing an agency-level Scorecard.
Formula for aggregating data presented in Partner
Scorecard ratings
Aggregate Numerator  Aggregate Denominator=Result
Example:
Numerator country1ð ÞþNumerator country2ð Þ
Denominator country1ð ÞþDenominator country2ð Þ¼ Result
Agreed, transparent criteria (see Table 3) were ap-
plied to aggregated data to produce a draft Score-
card for each signatory. Where insufficient data were
available to enable a rating, a ‘question mark’ rating
was produced. Two data points were collected: 2009
(as the latest available year) and baseline data (for
the period 2005–2007, depending on the most recent
data that each participating signatory could provide).
Scorecards for Development Partners were based on
aggregated data, which could mask variable performance
across different countries. In this paper we report on over-
all aggregated data. However, disaggregated (country-level)
ratings were also provided (www.ihpresults.net) so that
the performance of each Development Partner could be
viewed on a country-by-country basis.
Scorecards were shared with all participating signator-
ies to ensure that the interpretation and presentation of
data were accurate. The data and Scorecards were ana-
lysed by IHP+Results and an independent synthesis of
the findings, with conclusions and recommendations
based on this evidence, was presented in IHP+Results
2010 Annual Performance Report. A full description of
IHP+Results’ methodology, including a discussion of
observed limitations is available at www.ihpresults.net/
how/methodology
Results
Overview of findings
The following Figures show the Scorecard ratings for the
IHP+ signatories that participated in IHP+Results 2010
monitoring. The following sections draw on and discuss
data presented in Figures 1 and 2, and in Table 4
(below). Detailed data are available at www.ihpresults.
net/data
The IHP+Results monitoring generated data on a
range of indicators that we present grouped according to
the principles of the Paris Declaration (see above). In
our assessment we found that most participating coun-
tries and Development Partners had made some pro-
gress in improving how they were delivering health aid
in line with the Paris principles. Development Partners
generally performed well in terms of agreeing to high-
level frameworks for delivering aid according to recipi-
ent countries’ priorities. However, performance in terms
of strengthening and using country systems was below
expectations, and performance in providing predictable
financing through multi-year commitments was mixed.
Countries that experienced the strongest performance
by Development Partners (against the agreed reporting
framework) were Ethiopia, Mozambique and Mali, while
performance was more limited in other countries, some
of which were more recent signatories.
Country ownership
A key indicator of country ownership is the existence of
a ‘country compact’. A country compact is an agreement
between government and Development Partners that
sets out principles and commitments on how health aid
will be managed in support of the national health plan.
Table 3 Criteria for scorecard ratings
Target
achieved
Target not reached,
but there is demonstrated
evidence of progress towards
reaching the target.
No demonstrated
evidence of progress
towards the target.
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Figure 1 Overview of Development Partner performance.
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Figure 2 Overview of IHP+Country Government performance.
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All IHP + countries reviewed met the target of having a
national health plan or strategy in place (2 Ga). By 2009,
four countries (Ethiopia, Mali, Mozambique and Nepal)
had also agreed a country compact and two (Burundi
and Niger) had equivalent agreements in place (1 G).
The remaining countries had all expressed an intention
to develop country compacts. While a country may have
a country compact, not all Development Partners in that
country were a signatory. In Ethiopia, Mali, Mozam-
bique and Nepal (1DP) more than 70%b of Development
Partners surveyed indicated that they had signed the
relevant country compacts. In all countries where the
government reports the existence of a compact, the ma-
jority of Development Partners reported having signed
up to that compact.
Another indicator of country ownership is alignment be-
tween Development Partners programs and recipient coun-
tries’ national priorities. Findings from the IHP+Results
monitoring indicate that overall, Development Part-
ners have become more aligned with national prior-
ities: an increasing proportion of health aid is reported
on national budgets (2DPa); Development Partners are
meeting the agreed target (50%) on providing training
and capacity building assistance that is in line with na-
tional priorities; and that there is a greater use of a
programme-based approach (2DPb) to health aid, ra-
ther than the provision of support through stand-alone
projects. Across all the countries surveyed, the overall
proportion of health aid reported on the national
budget increased from 52% at baselinec to 79% in 2009,
against a target of 85%. However, only five participat-
ing Development Partners actually met this target (the
Global Fund; Spain; Sweden; UNICEF and the World
Bank), while a further four reported some progress in
2009 compared with their baseline data (EC, UK,
UNAIDS, WHO). All Development Partners that pro-
vided data acknowledged that they had already met the
target of providing 50% capacity building that is
aligned with national priorities. Eleven of the 15 Devel-
opment Partners surveyed reported that they had met
the target of 66% of aid delivered through programme
based approaches (Australia, Belgium, EC, GAVI, the
Global Fund, the Netherlands, Sweden, UNAIDS,
UNICEF, WHO and the World Bank).
Mutual accountability and managing for results
A single performance assessment framework is deemed
central to a government’s efforts to measure health out-
comes, monitor progress and identify areas of under-
performance. Fragmented performance frameworks and
information systems, and high levels of stand-alone pro-
ject-based monitoring hinder governments’ efforts to
have a comprehensive and coherent overview of progress
and incurs high transaction costs.
Seven of the ten countries surveyed reported that they
had a single national performance framework in place
(6 G) while 58% of the Development Partners active in
these countries claimed that they were using the national
framework as the primary basis to assess the perform-
ance of their health aid (6DP) (Table 4). However it was
not evident that Development Partners were using the
national framework as the sole or primary basis to assess
the performance of their own health aid as some
reported that they requested additional indicators that
went beyond the national framework. IHP+Results did
not assess the quality of the country performance frame-
work, nor the extent to which the national performance
framework covered the private and non-government
sectors.
IHP+Results also asked countries to report if they had
a process of mutual assessment of progress in the health
sector (7 G). Seven of ten countries (Burundi, DRC,
Ethiopia, Mali, Mozambique, Nepal and Niger) reported
having a mutual assessment process in place. The major-
ity of Development Partners participated in these mutual
assessment processes in four of the seven countries
Table 4 Development Partner responses to IHP+ country
government actions
Country Compact
or Equivalent
Performance
Framework
Mutual Accountability
Government
report
DP
signed*
Government
report
DP
use
Government
report
DP
use
Burkina Faso N / A** 8 / 10 N / A
Burundi 8 / 10 6 / 10 5 / 10
DRC N / A N / A 3 / 9
Djibouti N / A N / A N / A
Ethiopia 10 / 11 9 / 11 9 / 11
Mali 10 / 10 9 / 10 6 / 10
Mozambique
13 / 14 12 / 14 10 / 14
Nepal 7 / 9 7 / 9 7 / 9
Niger 5 / 9 6 / 9 4 / 9
Nigeria N / A N / A N / A
* Number of Development Partners positively reporting against this indicator over
the number of Development Partners that were active in the country and
participated in IHP+Results 2010 monitoring.
** N/A: Not Applicable.
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(7DP), while a minority of Development Partners par-
ticipated in the process in the other two countries.
The Global Fund and Norway consider this not ap-
plicable to them while the GAVI Alliance reports not
participating.
Transparent and responsible financing
There has been mixed progress in securing transparent
and responsible health sector financing in the countries
monitored. The key indicator for this, for Development
Partners, is the percentage of health aid that is commit-
ted to countries on a multi-year (three years or more)
basis (3DP). Overall the proportion of finance provided
by Development Partners through multi-year commit-
ments fell from 75% to 70% between baseline data and
2009, against a target of 90%. However, nine of fifteen
Development Partners (Belgium, EC, GAVI, Nether-
lands, Norway, Sweden, UK, UNFPA and the World
Bank) were providing 90% or more of their health aid
through multi-year commitments in 2009. When meas-
uring the ability of Development Partners to disburse
funds to countries on time (4DP), the survey showed
that 95% of Development Partner funding was being dis-
bursed during the year in which this had been commit-
ted to the country, compared with 92% at baseline
(against a target of 90%).
IHP+ country government performance on transparent
and responsible financing was measured in terms of the
proportion of national budgets allocated to health. Five
governments (Burkina Faso, Burundi, Djibouti, Nepal and
Niger) increased the proportion of their national budgets
allocated to health (3G). However these increases were
widely variable and none of the African governments
monitored had yet met the Abuja target [19] of 15% of na-
tional budget allocated to the health sector, although Bur-
kina Faso neared the target with an allocation of 14.6% of
the national budget to health in 2009 and Nepal’s domestic
spending for health reached 7.6% in 2009 against a na-
tional target of 10% (Figure 3).
It is important to note that Figure 3 tracks changes in
the allocation of the national budget to health for each
surveyed country. However, direct comparisons between
countries are difficult because of how external sources
of funding have been reported by survey participants.
For example, Burkina Faso and Mozambique excluded
external assistance in their calculations of the national
budget allocated to health, while Djibouti and Niger
included external assistance and Burundi, Ethiopia, Mali,
Nepal and Nigeria did not provide information on
whether they included or excluded external funding in
their reported figures.
The performance of governments in disbursing the
available health sector budgets also showed a mixed
picture (4G). We found that five (Burkina Faso, Djibouti,
Mozambique, Nepal and Niger) out of ten countries
increased the disbursement in their health budget while
three (Burundi, Mali and Nigeria) decreased the propor-
tion of funds disbursed.
Using and strengthening country systems
The IHP+encourages Development Partners to use, sup-
port and strengthen country systems whilst discouraging
Figure 3 Proportion of national budget allocated to health.
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the introduction of parallel or stand-alone systems. Two
such systems are used as IHP+Results indicators: first is the
systems used by government to procure goods and services
(5DPa), and second is the use of public financial manage-
ment systems (5DPb) for budgeting, planning and reporting
purposes. Both indicators measure the proportion of health
aid that is channeled through these government systems.
Overall the volume of Development Partner health aid that
uses country procurement systems has declined from 60%
(multiple agency baselines) to 53% in 2009 (against a target
of 80%). Only six Development Partners (Australia, Bel-
gium, the Global Fund, the Netherlands, Spain and Swe-
den) met the target of a 33% reduction in funds not using
the national procurement system.d However this result
might be underestimated because it does not take into ac-
count the fact that a number of Development Partners such
as the UK, the EC, the Netherlands, Norway and Sweden
provide considerable budget support that would use coun-
try procurement systems. The measure is not applicable for
the GAVI Alliance whose procurement is conducted
through a supra-national pooling mechanism administered
by UNICEF. There is also some variation from country to
country with, for example, a higher proportion of heath aid
was being channeled through country systems in Ethiopia
and Mali.
The third indicator of whether or not Development Part-
ners use recipient countries’ national systems is the use of
stand-alone project implementation units (PIUs) to man-
age their health aid (5DPc). The number of such stand-
alone PIUs in the ten surveyed countries was reduced by
29% between in 2009, compared to the baseline. This
represents significant progress towards achieving the tar-
get of a two-thirds reduction. UNFPA reported the largest
reduction in the use of PIUs from 21 to six. However, three
Development Partners) Belgium, Norway and the World
Bank) reported a small increase in the number of PIUs.
IHP + signatory countries have committed to im-
proving both their procurement and public financial
management systems. There were insufficient data to
determine whether procurement systems were im-
proving within countries so we could not report on
this indicator. The World Bank’s rating of overall (non-
health-specific) national public financial management sys-
tems gives some indication of general trends in aid. The
data suggest that three countries (Burkina Faso, Burundi
and Mozambique) had improved their public financial
management systems while two (Mali and Nepal) had seen
a deterioration between 2005 and 2009. Five countries
were considered to adhere to ‘good practices’ as defined by
the World Bank (Burkina Faso, Ethiopia, Mali, Mozam-
bique and Niger)d . In these five countries 63% of Develop-
ment Partner funding was reported to have used country
financial management systems in 2009, an increase of 18%
over the baseline.
Development Partners performance
No single Development Partner met all of the
selected targets in all of the countries. However, over-
all, more targets were met than were not met. The
Netherlands recorded the highest number of targets
met (eleven out of twelve) followed by World Bank
(nine) and Sweden (eight). (Australia has also met the
targets for eight indicators but this it only delivers
health aid to one of the ten countries surveyed). Only
two Development Partners reported achieving the tar-
get or making progress on all the indicators: Sweden
and the UK (although not necessarily in all countries).
On the whole, Development Partners reported pro-
gress. All Development Partners reported no progress
on two or less targets except for WHO (three targets
with no progress) and Norway (five targets with no
progress). However, further investigation found that Nor-
way’s apparent poor performance was partly related to
Norway’s emphasis on channeling aid through multilateral
channels rather than bilateral ones, and to its recent shift
from health projects and sector budget support to provid-
ing more general budget support. Such a change should
reflect an improved performance score. But limitations in
the evaluation methodology on how to appropriately as-
sess budget support against the full set of IHP+Results
indicators contributed to Norway scoring poorly. An over-
view of these results is presented in Figures 1 and 2
(above).
Development Partners have improved the effectiveness
of their health aid most of all in Ethiopia, Mali and Mo-
zambique, followed by Nepal and Burkina Faso. There
has been less improvement in Burundi, Djibouti, DRC,
Niger and Nigeria. Detailed disaggregated ratings for
each participating country can be found at www.ihpre-
sults.net/results/data
Most Development Partners provided sufficient data
to measure progress against all the targets. The two
main exceptions were GAVI and UNAIDS. GAVI
reported that three targets were not applicable and data
were not available for two of the targets. UNAIDS
reported that two targets were not applicable and data
were not available for an additional two targets. Austra-
lia and Belgium each indicated one target for which data
were not available, and the Global Fund (two), Nether-
lands (one), Sweden (one) reported targets that were not
applicable to their way of delivering aid.
Country Government Performance
Six countries reported having a country compact, a results
framework and a mutual accountability process. These
included early IHP+ signatories, Ethiopia, Nepal, Mali,
Mozambique and Burundi, as well as a more recent signa-
tory, Niger.
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Five countries reported having achieved seven of the
nine targets for which data were available: Burundi,
Ethiopia, Mali, Nepal and Niger; and Mozambique
reported having achieved six targets. The remaining
countries met four (Burkina Faso and DRC) or three
(Nigeria and Djibouti) of the targets. Country govern-
ments performed best at having a national health plan
in place (all ten countries) followed by having an agreed
performance framework in place (seven countries). At
the other end of the scale, no countries met the target
for the proportion of public funding allocated to health,
and only three countries (Djibouti, Nepal and Niger)
met the target for disbursing their approved annual
health budget.
Discussion
While this paper has been structured around the IHP
+Results process, it raises a number of broader issues
such as the future of the IHP + itself and the role of in-
dependent evaluation and performance ratings in pro-
moting positive behaviour change amongst Development
Partners and recipient governments.
As far as the findings of IHP+Results are concerned,
the first question to consider is whether they say any-
thing useful. The answer to this is a qualified ‘yes’. The
formal and structured process of monitoring and measur-
ing certain indicators has enabled a number of useful and
authoritative conclusions about implementing the Paris
agenda within the health sector to be made. For example,
we believe that IHP+Results has been able to describe and
measure some incremental improvements in the strength-
ening of national planning processes and of principles
around mutual accountability (through the global compact
and country compacts). It has also shown some measur-
able progress in Development Partners aligning their sup-
port with national budgets and making greater use of
programme based approaches.
It has also documented a lack of progress in the use of
country-based financial management and procurement
systems and in the reduction of duplicative and parallel
performance reporting frameworks and information sys-
tems. These findings, by virtue of being measured
through a systematic and structured process, can be a
powerful catalyst for ensuring further improvement in
the way that health aid is harnessed to support health
improvement and health systems development.
However, there are also several limitations and weak-
nesses associated with the work of IHP+Results. First, the
findings only cover those Development Partners and
countries who agreed voluntarily to participate in the
evaluation (selection bias).
Second, the data used to generate the measurable
indicators for each actor were submitted by the actors
themselves (information bias) and were not independ-
ently verified.
Third, the indicators used by IHP+Results were not com-
prehensive or exhaustive, a weakness that applies to the
indicators used to evaluate the Paris Declaration more
generally. For example, the evaluation of the Paris Dec-
laration does not include measures of the transaction
costs involved in countries applying for funding from
different sources or of having to set up multiple country
level governance structures. Neither do they cover the
important issue of the transparency of funding decisions
and disbursements.
Fourth, the methods employed by IHP+Results to
measure performance are new and require ongoing re-
finement and improvement. Some of the indicators
selected were found to be less useful than anticipated.
For example, on the provision of coordinated capacity
development/technical assistance (2DPb) and engage-
ment of civil society (8 G/8DP). And as explained previ-
ously, the methodology does not fully capture progress
when donors shift to general budget support from pro-
ject-based modalities or sector budget support. Finally,
mainly due to resource constraints, the evaluation meth-
odology did not include the qualitative data necessary to
interpret and understand the quantitative scores and rat-
ings - for example, where we collected data on the exist-
ence of a policy framework, it was not accompanied by
any description or measure of the quality of that per-
formance framework. Similarly, concepts like ‘mutual ac-
countability’ are complex and multi-dimensional and
cannot be fully understood or measured through a set of
quantitative indicators without some contextual and
qualitative analysis.
These limitations and weaknesses should not be viewed
as a criticism of IHP+Results. Rather they reflect the in-
herent difficulty of rigorously and usefully monitoring the
behaviour of multiple institutions operating across mul-
tiple countries within a complex system. It also reflects a
lack of available and reliable data which is a weakness that
needs to be addressed by Development Partners and gov-
ernments, rather than by an independent evaluator such
as IHP+Results.
In order to improve the prospects for verifying self-
reported data in future, IHP+Results will take steps to
situate future data collection as an in-country process
and also encourage a discussion of draft results by in-
country stakeholders. The engagement of local academic
organisations or other civil society organisations in veri-
fying data will therefore be critical. A number of add-
itional methodological and process amendments were
discussed and agreed with IHP+ signatories (through the
IHP+working group on mutual accountability) to be
implemented in the ongoing 2012 IHP+monitoring exer-
cise (taking place from February to July, and with a report
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expected in September 2012). These issues include – pro-
viding clearer definition on key terminology (including
when a Development Partner is ‘active’ in a country and
should therefore provide data); and stronger measures of
civil society engagement. Participation is also strengthened
with 15 Development Partners and 19 countries opting to
complete IHP+of monitoring in 2012 (up from 10 in
2010); broadly the twenty-five participants as in 2010 are
repeating the exercise.
Notwithstanding these changes and the need for meth-
odological improvements and better data, it is important
to note the ground-breaking nature of IHP+Results. For
the first time, a structured, independent and transpar-
ent evaluation of the performance and behaviours of
both Development Partners and country governments
has been conducted; and in a way that allows for com-
parisons between actors as well as comparisons over
time.
While the validity of the methods and data used to
evaluate aid effectiveness and institutional behaviour is
important, the process of measurement and the publica-
tion of results are equally important and are a vital part of
improving mutual accountability. In theory, the adoption
of a Scorecard approach will help change behaviour
through peer pressure, public scrutiny and increased
transparency of any gap between the rhetoric and practice
of aid effectiveness. This should also help shift the balance
of power between governments, donors and civil society
organisations in ways that will improve alignment, har-
monisation and health systems strengthening.
However, in moving forward, there is a need to expand
the scope and coverage of the monitoring. Not all IHP+
signatories opted to participate in the IHP+Results
process. Notable absentees included the Bill and Melinda
Gates Foundation. The biggest bilateral donor, the US
government, is not even a signatory of the IHP+. These
two absentees, particularly because of their significant in-
fluence leave a significant gap in any analysis of the mu-
tual accountability of development partners and recipient
countries within the health sector.
The Busan Outcome Document signals a shift from ‘aid
effectiveness’ to what has been called ‘development effect-
iveness’ in which a greater emphasis is placed on results
and on the role of non-government actors/donors as well
as public-private partnerships. It also signals a greater
focus on the outcomes of aid rather than on the process
of managing and transferring aid. In many ways, the
health sector is ahead of the game because the IHP+glo-
bal compact already stresses results and has been signed
by private actors (Bill and Melinda Gates Foundation) and
the major global health partnerships (the GAVI Alliance
and Global Fund). The agreement at Busan, which
emphasised transparency and accountability, also
heightens the relevance of IHP+, not just for the health
sector but also for other sectors that could learn from
the IHP + experience. However, Busan does make a shift
from Paris in diluting commitment and attention to
alignment and harmonisation.d
The Busan Outcome Document also reflects the
continued importance of country ownership and that
much work remains to be done in this area. This has
been a focus for IHP+. An aim of the IHP + should
be to support the development and implementation
of tools and instruments which will help foster better
quality national plans and strengthen country owner-
ship, and increase Development Partner alignment to-
wards country-owned plans and strategies. Notable
amongst these is the Joint Assessment of National
Strategies (JANS) approach which seeks to develop a
shared method of assessing and strengthening na-
tional health strategies, thereby increasing partner
confidence in those strategies, securing more predict-
able and better aligned funding, and reducing trans-
action costs arising from multiple separate agency
assessments.
The value of an independent and external review of
progress is clear from the experience of IHP+Results.
The experience has underlined the importance of on-
going monitoring of aid effectiveness, which at the
time of writing is unclear as the new set of post-
Busan indicators will be agreed later in 2012. Busan
signalled increased importance of transparency and
accountability in development which requires data in
the public domain, and on-going monitoring. This is
what IHP+Results does. The IHP+Results experience
can form the basis for on-going improvements in the
coordination, implementation and effective use of de-
velopment assistance for health. It is important that
the progress in evaluation reflected in the findings
reported here is built upon. Valuable investments
have been made in developing a methodology and
evaluation instruments that could be built upon.
Any future monitoring of IHP +will need to be af-
fordable and feasible. But it will be important to
recognize the trade-off between trying to achieve this
and ensuring a comprehensive set of both qualitative
and quantitative data. The key factors that seem to
enable a more viable long term process include -
strong country ownership, agreed reporting frame-
works and process, explicit commitments, voluntary
reporting, the perception that the principal purpose
of the monitoring process is to provide credible data
and analysis to feed ongoing dialogue between com-
mitted partners.
For a long time the development community has
been emphasising the importance of country owner-
ship and leadership. While the Paris Declaration and
IHP + have strengthened both country ownership and
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leadership translating these principles into better sys-
tems and better results needs Development Partners
to stay the course.
Conclusion
The global financial crisis is going to reduce aid spend-
ing and has led to an increased focus on results and
value for money. In light of the sustained (if not grow-
ing) need to fund health programs, it seems even more
important that aid is used effectively to maximise the
achievement of health goals. The findings of this study
suggest that the IHP+ is making a positive contribution
to improving aid effectiveness in the health sector (at
least in the ten countries where the study was com-
pleted, and for those fifteen Development Partners that
participated) in strengthening country ownership, har-
monisation and alignment. However progress is varied,
both across countries and between and within Develop-
ment Partner organizations, and it seems clear that there
are particular challenges associated with strengthening
and using country systems, which suggest that this is a
necessary focus for the IHP+ going forward.
External, independent monitoring, including IHP+Results,
has the potential to help strengthening accountability
in the health sector, and beyond. But there is a clear
need to ensure that civil society organisations have
the capacity to engage in a meaningful way. Whilst
the investments made in IHP+Results methodology
and tools have shown that sector level aid effective-
ness monitoring can provide credible results, and can
generate useful findings, there are also limitations with
IHP+monitoring that need to be addressed. This is not
surprising given the challenge of rigorously monitoring
multiple Development Partners across multiple countries
within a complex system. The findings presented here sug-
gest that the health sector is ahead of the game – in terms
of having an established mechanism to promote alignment
and harmonisation, and having a relatively advanced moni-
toring framework and methods. But to capitalise on this ad-
vantage IHP+ signatories should reaffirm commitment to
the IHP+, actively participate in monitoring and evaluation
processes and strengthen in-country capacity notably
amongst civil society organizations.
Endnote
ahttp://www.aideffectiveness.org/busanhlf4/images/
stories/hlf4/OUTCOME_DOCUMENT_-_FINAL_EN.
pdf
bIn a number of instances we refer to a % of Develop-
ment Partners. This is because the denominator (the
number of Development Partners active in each country)
varies and the numerator (achievement of a target by
Development Partner in a country) is not consistent be-
cause some development partners achieve a target in
one country and not in another. The % aggregates the
findings for all the countries
cBaseline data covered a series of years (2005–2007),
depending on the data that respondents were able to
provide
dThere are essentially two targets for Development
Partner use of both national procurement and public
financial management systems: a reduction in funds
not using those systems, and an absolute target for
the proportion of funds using those systems. For
more information on the Paris Declaration targets
(which are the basis of IHP+Results targets) see
http://www.oecd.org/dataoecd/57/60/36080258.pdf
eData (and therefore ratings) on the strength of country
procurement and public financial management systems
were taken from existing sources: for procurement Paris
Declaration monitoring data was used where available; for
public financial management systems, World Bank data
Country Policy and Institutional Assessment (CPIA)/PFM
data were used. Whether a country ‘adhered to accepted
good practices’ was determined by the OECD and World
Bank scores shown in these data, and the Paris Declar-
ation targets. For example, if a country’s PFM system
scored less than 3.5 the Paris Declaration target includes
no explicit expectation that Development Partners will
channel their funding through that system; the compar-
able score for country procurement systems was B (on a
four-point scale A-D).
fSee Busan Outcome Document for more details: http://
www.aideffectiveness.org/busanhlf4/images/stories/hlf4/
OUTCOME_DOCUMENT_-_FINAL_EN.pdf
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